Zaragoza acoge la I Jornada de la Sociedad Española de Microfisiología y Organ-on-Chip (SESMOoC)
3 noviembre, 2025PFIZER – CanAge Collaborate Grant Program 2025
4 noviembre, 2025
CSL’s RAI aims to fast-track discovery of innovative biotherapies through partnerships between CSL and global research organisation and companies.
- Up to USD 400.000 over two years
- CSL scientific champion assigned to each project
- Focused on early-stage projects
- Simple and fast 300-word initial application
- Clear and transparent timelines
- Open to research organisations (universities, medical research institutes, hospitals) and companies (start-ups, biotechs)
BD and commercialization representatives from research organizations and companies are invited to register their organization’s interest to participate in the 2026 RAI. Please email RAI@csl.com.au no later then 12th December 2025 expressing your interest to participate.
Each research organization or company must nominate one BD or commercialization representative to act as the primary point of contact with CSL. The focus areas will be announced with the registered organizations via webinars and flyers ahead of online applications opening. Scientists who wish to apply will have to submit a 300-word online abstract outlining their proposal come January 2026. The information sessions wil begin in February 2026.